Omnicell (OMCL) investor relations material

Strategic direction and innovation

• Focus on transforming medication management with the Titan XT platform and OmniSphere cloud solution, aiming for a step change in health system operations.

• Emphasis on customer-centric innovation, leveraging an innovation center to co-develop solutions with clients.

• OmniSphere, launching in the first half of next year, is designed as a cloud-native platform to centralize data, analytics, and device connectivity.

• Hardware and software are positioned as complementary, with the new hardware enabling seamless cloud adoption when customers are ready.

• The company is committed to supporting customers throughout the product lifecycle, not just at implementation.

Market positioning and competitive landscape

• Medication cabinets have become standard of care in U.S. acute care hospitals, expanding the market opportunity.

• The refresh cycle is timed alongside a major competitor, with a focus on solution architecture, customer experience, and financing flexibility as differentiators.

• Leasing is highlighted as a key sales motion, particularly effective in converting competitor accounts and matching customer cash flows.

• The company has a track record of modest share gains and aims to leverage the refresh cycle for further growth.

• Robust sales pipeline and strong customer engagement are expected to drive bookings and revenue over a multi-year journey.

Financial strategy and capital allocation

• Margin expansion is a priority, with EBITDA growth targeted at three times the rate of revenue growth for 2026.

• Investments are ring-fenced for critical product launches, while cost discipline is applied to back-office and support functions.

• Nearly $300 million in cash and access to additional capital support leasing initiatives and strategic flexibility.

• Capital allocation is focused on core offerings, leasing opportunities, and potential tuck-in acquisitions, with no current stock repurchase program.

• The company is responsive to investor feedback, balancing innovation with profitability and portfolio optimization.